Thus, it is tempting to speculate that the altered glycosylation (and increase in E-selectin binding potential) on malignant cells is associated with the epigenetic changes in DNA methylation and histone modulation that occurs during oncogenesis, possibly re-enforced by tumor-associated inflammation. This evidence concerns the gene SELE and neoplasm.